FeMoropopliteal AngioSculpt™ SCoring BallOon CaTheter Study
NCT ID: NCT00619788
Last Updated: 2010-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
50 participants
INTERVENTIONAL
2008-03-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The scoring balloon is a semi-compliant balloon encircled by 3 spiral struts with a nitinol scoring element, which theoretically provides targeted scoring of lesions, by concentrating the dilation force thus minimizing barotrauma, elastic recoil and uncontrolled dissection. This may improve the outcome of the intervention and reduce the number of stents required.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DCB Outcomes After Plain or Scoring Balloon for Vessel Preparation in Patients With Femoropopliteal Arterial Disease
NCT07136883
Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis
NCT04982367
A Post-Market Study of Drug-Coated Peripheral Balloon Dilatation Catheter in Treating Femoropopliteal Artery Stenosis or Occlusive Lesions.
NCT07187128
Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM)
NCT02813577
DCB Compared Stenting in Popliteal Lesions
NCT03739580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients receiving 4.0-5.0mm AngioSculpt Scoring Balloon Catheter (AngioScore, Inc.) for femoropopliteal use
4.0-5.0mm AngioSculpt Scoring Balloon Catheter
The AngioSculpt Scoring Balloon Catheter is a line of innovative angioplasty catheters comprising an angioplasty balloon surrounded by a unique system of nitinol scoring elements. Creating focal concentrations of dilating force, the scoring elements score arterial lesions as the balloon expands.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
4.0-5.0mm AngioSculpt Scoring Balloon Catheter
The AngioSculpt Scoring Balloon Catheter is a line of innovative angioplasty catheters comprising an angioplasty balloon surrounded by a unique system of nitinol scoring elements. Creating focal concentrations of dilating force, the scoring elements score arterial lesions as the balloon expands.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Length of lesion \>5 cm or 2 times the AngioSculpt balloon length (whichever is longer)
* Reference vessel diameter should be 4.0-6.0 mm
* Life altering claudication or critical limb ischemia (Rutherford 3-5)
* No untreated inflow-limiting arterial lesions
* At least single vessel run-off until the ankle
* The patient must be \> 18 years.
* Life-expectancy of more than 12 months
* The subject or legal guardian has been informed of the nature of the evaluation; agrees to its provisions and has signed informed consent
* The patient is capable to follow all evaluation requirements.
Exclusion Criteria
* The reference segment diameter is not suitable for available catheter design
* Length of lesion is ≥5 cm or requires more than two overlapping AngioSculpt balloon inflations (whichever is longer) to cover the entire lesion (however, more than two inflations are permitted within an acceptable lesion length)
* The patient has a known allergy to heparin, aspirin or other anticoagulant/antiplatelet therapies or a bleeding diatheses or is unable, or unwilling, to tolerate such therapies
* The patient has a history of prior life-threatening contrast media reaction
* The patient is currently enrolled in another investigational device or drug trial
* The patient is currently breast-feeding, pregnant or intends to become pregnant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AngioScore, Inc.
INDUSTRY
Flanders Medical Research Program
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Flanders Medical Research Program
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Peeters, MD
Role: PRINCIPAL_INVESTIGATOR
Imelda Hospital, Bonheiden, Belgium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imelda Hospital
Bonheiden, , Belgium
AZ St-Blasius
Dendermonde, , Belgium
Herzzentrum
Leipzig, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMRP-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.